Related Experiment Video

Updated: May 3, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

7.1K

Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells

Elzbieta Gocek1, Anargyros N Moulas, George P Studzinski

  • 1Department of Protein Biotechnology, Faculty of Biotechnology, University of Wroclaw , Wroclaw , Poland .

Critical Reviews in Clinical Laboratory Sciences
|January 23, 2014
PubMed

Insights

Cytoplasmic non-receptor tyrosine kinases (NRTKs) are crucial for cell signaling and function. Dysregulation of NRTKs is linked to cancer, driving research into targeted therapies.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Oncology

Background:

  • Protein tyrosine kinases (PTKs) are enzymes regulating cellular functions through tyrosine residue phosphorylation.
  • Cytoplasmic non-receptor tyrosine kinases (NRTKs) mediate signals from extracellular stimuli, impacting cell differentiation, apoptosis, survival, and proliferation.
  • NRTK dysregulation is implicated in malignant transformation and carcinogenesis.

Purpose of the Study:

  • To review the structure, function, and signaling pathways of nine major NRTK families.
  • To elucidate the role of NRTKs in both normal and cancerous cellular processes.
  • To highlight the therapeutic potential of targeting NRTKs in cancer treatment.

Main Methods:

  • Literature review and synthesis of existing research on NRTKs.
  • Analysis of NRTK structure, function, and signaling mechanisms.
  • Examination of NRTK involvement in carcinogenesis and therapeutic strategies.

Main Results:

  • NRTKs play a critical role in fundamental cellular processes.
  • Aberrant NRTK activity is a hallmark of many cancers.
  • Several NRTK inhibitors are approved or under investigation for cancer therapy.

Conclusions:

  • NRTKs are vital regulators of cellular signaling with significant implications in cancer.
  • Understanding NRTK pathways is essential for developing novel anti-cancer treatments.
  • Targeting NRTKs offers a promising therapeutic avenue for various malignancies.
Keywords:
Cancerleukemianon-receptor tyrosine kinasessignal transduction

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

951
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

13.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K